...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Method of Hypertonic Saline Administration: Effects on Osmolality in Traumatic Brain Injury Patients
【24h】

Method of Hypertonic Saline Administration: Effects on Osmolality in Traumatic Brain Injury Patients

机译:高渗盐水管理方法:对创伤性脑损伤患者渗透压的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Hypertonic saline (HTS) is an effective therapy for reducing intracranial pressure (ICP). The ideal method of administration is unknown. The purpose of this study was to evaluate the method of HTS infusion and time to goal osmolality. A retrospective cohort analysis was conducted in severe TBI patients with ICP monitoring in place who received 2 doses of HTS. Patients were divided into bolus versus continuous infusion HTS cohorts. The primary outcome was median time to goal osmolality. Secondary outcomes included percentage of patients reaching goal osmolality, percent time at goal osmolality, mean cerebral perfusion pressure (CPP) and ICP, ICU length of stay, and mortality. Safety outcomes included rates of hyperchloremia, hypernatremia, and acute kidney injury (AKI). 162 patients were included with similar baseline characteristics. Time to goal osmolality was similar between cohorts (bolus 9.78 h vs. continuous 11.4 h, p = 0.817). A significant difference in the percentage of patients reaching goal osmolality favoring the continuous group was found (93.9% vs 73.3%, p = 0.003). The continuous group was maintained at goal osmolality for a higher percentage of osmolality values after reaching goal (80% vs. 50%, p = 0.032). No difference was seen in CPP, ICP, length of stay and mortality. Rates of hypernatremia were similar, but significant higher rates of hyperchloremia (0.77 vs 1.58 events per HTS days, p < 0.001) and AKI (0% vs 12.9%, p = 0.025) were observed in the continuous cohort. Although no difference in time to goal osmolality was observed, continuous HTS was associated with a higher percentage of patients achieving goal osmolality. (C) 2017 Elsevier Ltd. All rights reserved.
机译:高渗盐水(HTS)是减少颅内压(ICP)的有效疗法。理想的管理方法是未知的。本研究的目的是评估HTS输注和目标渗透性的时间的方法。回顾性队列分析在严重的TBI患者中进行了ICP监测,以2剂HTS接受2剂HTS。患者分为推注与连续输注HTS队列。主要结果是目标渗透性的中位时间。二次结果包括达到目标渗透压患者的百分比,渗透渗透压的百分比,平均脑灌注压力(CPP)和ICP,ICU的住宿时间和死亡率。安全结果包括高氯血症,高鼻血症和急性肾损伤(AKI)的税率。 162名患者包含类似的基线特征。在群组之间存在渗透性的时间相似(推注9.78h与连续11.4小时,P = 0.817)之间相似。发现达到连续组的患者患者患者百分比的显着差异(93.9%vs 73.3%,p = 0.003)。在达到目标后,连续基团保持液体渗透压率较高百分比的渗透压值(80%对50%,P = 0.032)。在CPP,ICP,住宿时间和死亡率上没有差异。在连续队列中观察到高胆血症的高血症率相似但高氯血症率显着较高的高氯血症率(每次HTS天,P <0.001)和AKI(0%vs12.9%,p = 0.025)。虽然观察到目标渗透性的时间没有差异,但连续的HTS与达到目标渗透压患者的较高百分比有关。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号